4basebio Statistics
Total Valuation
4basebio has a market cap or net worth of GBP 151.74 million. The enterprise value is 164.52 million.
Market Cap | 151.74M |
Enterprise Value | 164.52M |
Important Dates
The last earnings date was Friday, December 27, 2024.
Earnings Date | Dec 27, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
4basebio has 12.81 million shares outstanding. The number of shares has increased by 1.59% in one year.
Current Share Class | n/a |
Shares Outstanding | 12.81M |
Shares Change (YoY) | +1.59% |
Shares Change (QoQ) | +3.16% |
Owned by Insiders (%) | 16.50% |
Owned by Institutions (%) | 34.60% |
Float | 2.54M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 248.82 |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -16.72 |
EV / Sales | 276.04 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -18.31 |
Financial Position
The company has a current ratio of 2.73
Current Ratio | 2.73 |
Quick Ratio | 1.53 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | -1.72 |
Interest Coverage | -18.65 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -54.30% |
Return on Capital (ROIC) | -62.02% |
Revenue Per Employee | 5,901 |
Profits Per Employee | -97,406 |
Employee Count | 84 |
Asset Turnover | 0.05 |
Inventory Turnover | 0.65 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +74.27% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +74.27% |
50-Day Moving Average | 1,270.00 |
200-Day Moving Average | 1,323.78 |
Relative Strength Index (RSI) | 30.30 |
Average Volume (20 Days) | 1,085 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, 4basebio had revenue of GBP 596,000 and -9.84 million in losses. Loss per share was -0.79.
Revenue | 596,000 |
Gross Profit | 415,000 |
Operating Income | -10.20M |
Pretax Income | -10.63M |
Net Income | -9.84M |
EBITDA | -9.63M |
EBIT | -10.20M |
Loss Per Share | -0.79 |
Balance Sheet
The company has 2.72 million in cash and 15.49 million in debt, giving a net cash position of -12.78 million or -1.00 per share.
Cash & Cash Equivalents | 2.72M |
Total Debt | 15.49M |
Net Cash | -12.78M |
Net Cash Per Share | -1.00 |
Equity (Book Value) | -5.22M |
Book Value Per Share | -0.41 |
Working Capital | 3.12M |
Cash Flow
In the last 12 months, operating cash flow was -8.33 million and capital expenditures -653,000, giving a free cash flow of -8.99 million.
Operating Cash Flow | -8.33M |
Capital Expenditures | -653,000 |
Free Cash Flow | -8.99M |
FCF Per Share | -0.70 |
Margins
Gross Margin | 69.63% |
Operating Margin | -1,711.58% |
Pretax Margin | -1,784.23% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
4basebio does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.59% |
Shareholder Yield | -1.59% |
Earnings Yield | n/a |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
4basebio has an Altman Z-Score of -2.69. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -2.69 |
Piotroski F-Score | n/a |